2027 Best Value Clinical and Industrial Drug Development Schools in the Middle Atlantic Region
[Clinical and Industrial Drug Development](/majors/health-care-professions/pharmacy-pharmaceutical-sciences/clinical-and-industrial-drug-development/) degree programs vary widely in price and payoff across the country. A high-value program keeps cost low while graduates go on to earn well.
To produce this 2027 ranking, College Factual evaluated 3 schools on the balance of cost and outcomes for clinical and industrial drug development students.
What’s on this page:
2027 Best Value Clinical and Industrial Drug Development Schools in the Middle Atlantic Region
Below are the schools that deliver the strongest value in clinical and industrial drug development, balancing cost against outcomes.
Best Value Clinical and Industrial Drug Development Schools
Temple University tops our 2027 list of the best value clinical and industrial drug development schools in the Middle Atlantic Region. Set in the city of Philadelphia, Temple University is a very large public institution. The average in-state cost of tuition and fees is $23,005, while out-of-state students pay about $38,805. Typical student debt for clinical and industrial drug development graduates is $26,259. Soon after graduation, clinical and industrial drug development degree recipients from Temple University generally make around $111,896. That is a strong return on a $26,259 median debt. The acceptance rate is 80%.
Students looking for strong value in clinical and industrial drug development will find it at Saint Josephs University, which ranked #2. Located in the city of Philadelphia, Saint Josephs University is a moderately-sized private not-for-profit university. In-state tuition and fees average $53,260. Clinical And Industrial Drug Development graduates carry a median of $26,426 in student loans. Early-career clinical and industrial drug development graduates make about $88,125. Set against $26,426 in median debt, that is a healthy payoff. Roughly 89% of applicants are accepted.
Stevens Institute Of Technology came in at #3 on our 2027 list of the best value clinical and industrial drug development schools. Set in the suburb of Hoboken, Stevens Institute Of Technology is a moderately-sized private not-for-profit institution. In-state tuition and fees average $63,462. Students borrow a median of $26,767 to complete the clinical and industrial drug development program here. Soon after graduation, clinical and industrial drug development degree recipients from Stevens Institute Of Technology generally make around $87,055. Weighed against typical debt, the earnings make a compelling case for value. Roughly 48% of applicants are accepted.
Narrow Clinical and Industrial Drug Development Schools by State
More Clinical and Industrial Drug Development Rankings
View All Clinical and Industrial Drug Development Rankings >
Notes and References
This list is compiled by College Factual (MF_RANKING_2025), 2027 edition. Schools are scored on the balance of cost (tuition and student debt) against student outcomes (post-graduation earnings) — a measure of return on investment, drawn primarily from the U.S. Department of Education (IPEDS and College Scorecard).
Ranking method: College Major Best Value · 3 schools evaluated.
*Averages shown above reflect the top 3 ranked schools only.
- The Integrated Postsecondary Education Data System (IPEDS) from the National Center for Education Statistics (NCES), a branch of the U.S. Department of Education (DOE), serves as the core of our data about colleges.
- Some other college data, including much of the graduate earnings data, comes from the U.S. Department of Education’s (College Scorecard).
More about our data sources and methodologies.
